SRP118346 PRJNA408141 GSE104064 RNAseq data on HDAC Class IIa inhibitor (CHDI-00390576) dosed Q175 mice. WT and Q175 heterozygous (het) mice treated orally twice a day with vehicle (10% HPßCD), and Q175 mice treated with either 30 or 100 mg/kg orally twice a day CHDI-00390576. CHDI-00390576 is a Class IIa HDAC inhibitor. Mice were dosed from 4 weeks to 6 months of age. Overall design: Tibialis, striatum, cortex, heart and liver collected N = 8 per group (4M/4F). GSE104064